At its core, GPT-Rosalind is the first in a new series of models optimized for scientific workflows. While previous ...

The field of bioinformatics is witnessing a dramatic surge in data volumes due to the advent of advanced high-throughput technologies in areas such as ...

Immunological microcosms and genetic changes are central to understanding the mechanisms that drive disease progression and response to treatments. Research ...

Dr. Simon Sumer explains how AI‑driven protein design is shortening development cycles, improving screening efficiency, and ...

Anti-inflammatory breakfast foods may be able to help support your body's immune response and ease symptoms of allergies.

Rosalind, a biological language model for target discovery and genomics. Currently only available for US corporate customers.

GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.

Liquid biopsy enables genomic profiling in prostate cancer with high success rates. Learn more about its potential as a ...

OpenAI has introduced GPT-5.5, a new model designed for real-world computing tasks including coding, research, data analysis, ...

Malaria outbreaks are rising again in parts of southern Africa. Across the SADC (Southern African Development Community) ...

Learn how researchers used morphology and genetic analysis to reveal the identity of a mysterious golden orb found during a ...

This spring, the University of Tampa is shifting from planning to full-on construction for a five-story, riverfront Science ...